Atherosclerosis and Lipoproteins |
a Lavren
i
i
SalobirFrom the University Medical Centre, Department of Angiology, Ljubljana, Slovenia.
Correspondence to Ale
a Lavren
i
, Lek d.d., Research and Development, Celov
ka 135, 1526 Ljubljana, Slovenia. E-mail: alesa.lavrencic{at}lek.si
| Abstract |
|---|
|
|
|---|
Key Words: physical training flow-mediated dilation polymetabolic syndrome ultrasonography conduit arteries
| Introduction |
|---|
|
|
|---|
There is considerable evidence that increased shear stress via increased blood viscosity,12 heart rate and pulse pressure,13 and blood flow,14 which can all be a result of exercise, increases the production of NO from the arterial endothelium. Recent evidence suggests that these factors may contribute to persistent NO production in the period between exercise bouts. Experiments in animal models have demonstrated that chronic exercise caused an increase in NO synthase gene expression and endothelial release of NO, which was associated with improved endothelium-dependent dilation.15 16 In humans, there have been few studies investigating the effects of aerobic exercise training on endothelium-dependent dilation. These studies were performed in healthy subjects17 or patients with chronic heart failure,18 19 20 and they showed promising results.
The aim of our study was to discover whether physical training improves flow-mediated dilation in asymptomatic patients with the polymetabolic syndrome, which includes a cluster of cardiovascular risk factors: insulin resistance, hypertriglyceridemia, reduced HDL cholesterol, arterial hypertension, and increased thrombogenic potential.21 22 23
| Methods |
|---|
|
|
|---|
Clinical Examination
Before and after the intervention period, blood pressure, heart
rate, and anthropometric parameters were determined. All
parameters were determined by a single observer.
Systolic and diastolic blood pressures were
measured with a mercury sphygmomanometer after a minimum of 10 minutes
of rest in a sitting position. Heart rate at rest was taken from an ECG
recording. The body mass index was calculated as weight in
kilograms divided by the square of the height in meters. Waist
circumference was measured midway between the lower rib margin and the
iliac crest, at the end of a normal expiration. Hip circumference was
evaluated as the largest measurement in a horizontal plane around the
buttocks. The waist to hip ratio was then calculated.
Maximal Exercise Testing
Maximal exercise testing on a bicycle ergometer was performed
before and after the intervention period. A constant number of pedal
revolutions (60 to 80 per minute) was maintained while increasing the
resistance. The initial workload was 25 W, with 25-W increments every 3
minutes. Heart rate was monitored continuously, and blood pressure was
measured at the start of the test and at the end of each power
increment. The indications for terminating exercise testing were the
appearance of symptoms (exhaustion, shortness of breath, chest pain, or
pain in the legs), physical signs (an elevation of blood pressure
>250/120 mm Hg, a decrease of systolic blood pressure by
>10 mm Hg, an attainment of maximal heart rate, or a decrease of
heart rate), or ECG changes (ST-segment depression by >3 mm,
ST-segment elevation by >1 mm, or
arrhythmia).24 Patients in whom exercise testing
suggested coronary heart disease were excluded from the study,
as were the patients in whom any kind of pain, which could
represent an obstacle to physical training, appeared during the
exercise testing.
Physical Training
The subjects were randomly divided between the training and the
control group. The training group was scheduled for aerobic exercise 3
times weekly for 12 weeks, supervised by a physiotherapist. Each
session consisted of a 20-minute warm-up period and 30 minutes of
intense exercise on a bicycle ergometer at 80% of the previously
determined maximum heart rate. This intensity of training was attained
gradually in a period of 2 weeks, and, as the aerobic capacity of the
subjects improved, the workload was increased to keep the pulse rate at
a desired level. The heart rate was determined by palpation of the
carotid pulse by the subjects themselves.
Subjects in the control group were asked to maintain their habitual activities. In the training group, 14 subjects completed the study; their attendance at training sessions was 86%. One subject stopped with the training program earlier, mainly due to lack of motivation. In the control group, all 15 subjects completed the study.
Blood Sampling
Blood for analysis was sampled before the intervention
period and 3 to 7 days after the last training session. Blood was
collected in the morning after a 12-hour overnight fast. Blood samples
were drawn from the antecubital vein. Blood for the analysis of
glucose, insulin, lipids, apolipoproteins A-I and B, and lipoprotein(a)
[Lp(a)] was collected without additives. For the analysis of
big endothelin-1, the blood was collected in citrated tubes. The blood
was centrifuged, and samples of serum and plasma were
transferred to small plastic vials and stored at -70°C until
analyzed.
Laboratory Methods
The concentrations of serum glucose, total and HDL
cholesterol, and triglycerides were determined
by standard colorimetric assays (Ektachem 250
Analyzer, Eastman Kodak Co). LDL cholesterol
was calculated from the Friedewald formula.25
Apolipoproteins A-I and B were determined by immunonephelometric
assays26 (Behring). Lp(a) was measured by an ELISA
method27 using commercial kits (TintElize Lp(a), Biopool).
Insulin was determined by an immunoradiometric assay28
using commercial kits (INSI-CTK irma, Sorin Diagnostics).
Insulin resistance was estimated by homeostasis model
assessment.29 Big endothelin-1 was measured by an enzyme
immunoassay30 using commercial kits (Biomedica).
Ultrasound Measurements
Before and after the intervention period, each subject underwent
noninvasive study of a brachial artery to assess
endothelial and smooth muscle responses. The
high-resolution B-mode Diasonics VST ultrasound system with a 10-MHz
linear-array transducer was used to measure changes in
arterial diameter in response to reactive hyperemia
(with increased flow producing an endothelium-dependent
stimulus to vasodilation) and to glyceryltrinitrate
([nitroglycerin], GTN, an
endothelium-independent vasodilator). Each subject
rested in the supine position for 10 minutes before the first scan and
remained supine throughout the study. The right brachial artery was
scanned in longitudinal section above the elbow to find the clearest
images of the anterior and posterior wall layers. All measurements were
performed with the same position of the transducer and the arm. The
diameter was always measured at end-diastole, which was
determined with simultaneous monitoring of the ECG
(concurrent with onset of the QRS complex). Blood flow velocity was
measured using a pulsed Doppler signal at a 68° angle to the
vessel. Arterial blood flow was calculated from blood flow
velocity and arterial diameter. After a baseline brachial
artery diameter and blood flow velocity had been measured, a pneumatic
tourniquet was placed around the forearm and inflated to a pressure of
300 mm Hg for 4 minutes, followed by release. Blood flow velocity
was measured again 15 seconds after cuff deflation, and
arterial diameter was measured 45 to 60 seconds after cuff
deflation. Ten minutes later, baseline measurements were repeated. The
last measurements were taken 3 to 4 minutes after administration of 0.5
mg of sublingual GTN.
All measurements were carried out by the same investigator, who was blinded to the subjects characteristics. For assessment of the reproducibility of measurements, 10 subjects were selected randomly for repeated measurements of endothelium-dependent dilation. The correlation coefficient between the absolute differences and mean values of paired measurements was 0.86 (P<0.05).
The flow-mediated dilation was expressed as a percentage change of diameter after reactive hyperemia relative to the baseline scan. Likewise, the GTN-mediated dilation was expressed as a percentage change of diameter after GTN administration relative to the baseline scan.
Statistical Analysis
Variables showing a normal distribution, which was tested by
the Kolmogorov-Smirnov test, were expressed as means and SDs.
Asymmetrically distributed variables were described by median and
range. Baseline characteristics of the subjects in both groups were
compared by the unpaired Students t test for normally
distributed variables, by the Mann-Whitney U test for
asymmetrically distributed variables, and by the Fisher exact test
for attributive variables. The variables measured before and
after the intervention period were compared by the paired Students
t test. For correlation analysis, Pearsons
correlation coefficient was calculated for normally distributed
variables and Spearmans rank-correlation coefficient for other
variables. Multiple regression analysis was carried out to
find independent determinants for the variations in flow-mediated
dilation. The criterion for statistical significance was a P
value <0.05. All calculations were performed by the Statistica
computer program (StatSoft Inc, 1995).
| Results |
|---|
|
|
|---|
-blocker; and 4, statins) and the control group
(3 subjects were receiving angiotensin-converting enzyme
inhibitors; 4, calcium antagonists; 1, a
ß-blocker; 1, an
-blocker; 3, statins; and 4, fibrates). The
medication had not been changed during the last 6 months before the
study and remained the same during the study. Table 1
|
Vascular Studies
There was an improvement of 2% in flow-mediated dilation in the
training group after the training period (Table 2
). There was no significant change in
the GTN-mediated dilation or other hemodynamic
parameters.
|
Correlations
The baseline flow-mediated dilation was negatively correlated with
the resting heart rate (r=-0.49, P<0.01) and
waist-to-hip ratio (r=-0.40, P=0.03). The
negative correlation with insulin resistance almost reached statistical
significance (r=-0.34, P=0.07).
In the multiple regression model, which included the resting heart rate, waist-to-hip ratio, and insulin resistance, the baseline flow-mediated dilation turned out to be independently related only to resting heart rate (partial r=-0.49, P<0.01; R2=0.22, P<0.01).
| Discussion |
|---|
|
|
|---|
In our study, there was no change in insulin resistance, plasma lipids, or arterial blood pressure after training, which means that the improved endothelium-dependent dilation could not be explained by alterations in any of the known risk factors for atherosclerosis, which have been shown to be connected with impaired endothelium-dependent dilation.9 10 11 There was also no change in the plasma concentration of big endothelin-1, which is a precursor of a potent vasoconstrictor, endothelin-1.
Recent experimental data demonstrate that NO synthase gene expression in endothelial cell cultures is increased after exposure to increased shear stress32 and that chronically increased blood flow causes an increased endothelial release of NO.14 Moreover, a 10-day training program increased the vascular NO production and NO synthase gene expression in a dog model16 and was associated with increased endothelium-dependent dilation of coronary arteries.15 These experimental observations would support the notion that repetitive increases in vascular shear stress caused by physical training exert an upregulation of the NO synthase gene, which in turn provides enhanced synthesis and release of NO, resulting in an improvement of endothelial function. In our study, the patients performed leg training, whereas the improved flow-mediated dilation was measured on the brachial artery. This observation could be explained by the increased shear stress, which also occurs in the forearm vascular bed during leg exercise. This is supported by the findings of Kingwell et al,17 who showed that such training increased forearm blood flow and blood viscosity in the immediate postexercise period. Increased heart rate and pulse pressure, which are also induced by exercise, could contribute to increased shear stress as well.33
Only a few studies investigating the influence of physical training on endothelium-dependent dilation have been performed in humans, and most of them showed positive results. Kingwell et al17 showed that 4 weeks of moderate cycle training performed for 30 minutes 3 times a week in healthy subjects without cardiovascular risk factors significantly increased the basal release of NO in the forearm vascular bed, but no change in forearm blood flow in response to acetylcholine (an endothelium-dependent dilator) was observed, which could be due to the shorter duration of training compared with the one in our study. In 2 other studies,18 19 the influence of daily handgrip exercise on the endothelium-dependent dilation of arteries of the same arm was studied in patients with chronic heart failure, and after 4 weeks of training, an improvement in this parameter was found. Hambrecht et al20 showed that 6 months of cycle training improved both basal endothelial NO formation and acetylcholine-mediated endothelium-dependent dilation of the skeletal muscle vasculature in patients with chronic heart failure. In most of the previous studies,17 19 plethysmography was used to measure blood flow in conduit arteries, which reflects changes in the resistance arteries. In contrast, we determined endothelial function by measurement of the change in diameter of the conduit artery.
Until now there has been no prospective study to answer the question whether the improved endothelium-dependent dilation reduces cardiovascular morbidity and mortality. However, based on known data, it could be assumed that improved endothelium-dependent dilation is connected with a deceleration of the progression of atherosclerosis and its complications. A reduced release of NO from endothelial cells appears not only to be an indicator of atherosclerosis but also to contribute to its initiation and progression. An impaired production of NO leads to vasoconstriction, which results in turbulent flow and damage to the endothelium.34 NO also inhibits platelet adherence and aggregation, smooth muscle proliferation, and endothelial cellleukocyte interactions.35 36 All of these factors are known to contribute to the progression of atherogenesis.
In conclusion, our study showed the beneficial effects of physical training on early functional atherosclerotic changes of the arterial endothelium in patients with the polymetabolic syndrome, who are at great risk of cardiovascular diseases. This could be another indirect argument in favor of encouraging physical exercise as a therapeutic measure in patients with cardiovascular risk factors.
Received March 23, 1999; accepted July 21, 1999.
| References |
|---|
|
|
|---|
2.
Hakim AA, Petrovitch H, Burchfiel CM, Ross GW,
Rodriguez BL, White LR, Yano K, Curb D, Abbott RD. Effects of walking
on mortality among nonsmoking retired men. N Engl J
Med. 1998;338:9499.
3.
Bijnen FCH, Caspersen CJ, Feskens EJM, Saris WHM,
Mosterd WL, Kromhout D. Physical activity and 10-year mortality from
cardiovascular diseases and all causes. Arch
Intern Med. 1998;158:14991505.
4. Stray-Gundersen J, Denke MA, Grundy SM. Influence of life-time cross-country skiing on plasma lipids and lipoproteins. Med Sci Sports Exerc. 1991;23:695702.[Medline] [Order article via Infotrieve]
5.
Burchfiel CM, Sharp DS, Curb JD, Rodriguez BL, Hwang
LJ, Marcus EB, Yano K. Physical activity and incidence of diabetes: the
Honolulu Heart Program. Am J Epidemiol. 1995;141:360368.
6. Fagard RH. Prescription and results of physical activity. J Cardiovasc Pharmacol. 1995;25(suppl 1):2027.
7. Schuit AJ, Schouten EG, Kluft C, De Maat M, Menheere PPCA, Kok FJ. Effect of strenuous exercise on fibrinogen and fibrinolysis in healthy elderly men and women. Thromb Haemost. 1997;78:845851.[Medline] [Order article via Infotrieve]
8. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109142.[Medline] [Order article via Infotrieve]
9. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:14681474.[Abstract]
10. Sorensen KE, Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest. 1994;93:5055.
11. Celermajer DS. Endothelial dysfunction: does it matter? is it reversible? J Am Coll Cardiol. 1997;30:325333.[Abstract]
12. Wieczorek KM, Brewer AS, Myatt L. Shear stress may stimulate release and action of nitric oxide in the human fetal-placental vasculature. Am J Obstet Gynecol. 1995;173:708713.[Medline] [Order article via Infotrieve]
13.
Hutcheson IR, Griffith TM. Release of
endothelium-derived relaxing factor is modulated both
by frequency and amplitude of pulsatile flow. Am J
Physiol. 1991;261:H257H262.
14.
Miller VM, Aarhus LL, Vanhoutte PM. Modulation of
endothelium-dependent responses by chronic alterations
of blood flow. Am J Physiol. 1986;251:H520H527.
15.
Wang J, Wolin MS, Hintze TH. Chronic exercise enhances
endothelium-mediated dilation of epicardial
coronary artery in conscious dogs. Circ Res. 1993;73:829838.
16.
Sessa WC, Pritchard K, Seyedi N, Wang J, Hintze TH.
Chronic exercise in dogs increases coronary vascular nitric
oxide production and endothelial cell nitric
oxide synthase gene expression. Circ Res. 1994;74:349353.
17.
Kingwell BA, Sherrard B, Jennings GL, Dart AM. Four
weeks of cycle training increases basal production of nitric
oxide from the forearm. Am J Physiol. 1997;272:H1070H1077.
18.
Hornig B, Maier V, Drexler H. Physical training
improves endothelial function in patients with chronic
heart failure. Circulation. 1996;93:210214.
19.
Katz SD, Yuen J, Bijou R, LeJemtel TH. Training
improves endothelium-dependent vasodilation in
resistance vessels of patients with heart failure. J Appl
Physiol. 1997;82:14881492.
20.
Hambrecht R, Fiehn E, Weigl C, Gielen S, Hamann C,
Kaiser R, Yu J, Adams V, Niebauer J, Schuler G. Regular physical
exercise corrects endothelial dysfunction and improves
exercise capacity in patients with chronic heart failure.
Circulation. 1998;98:27092715.
21. Arnesen H. Introduction: the metabolic cardiovascular syndrome. J Cardiovasc Pharmacol. 1992;20(suppl 8):S1S4.
22. Davidson MB. Clinical implications of insulin resistance syndromes. Am J Med. 1995;99:420426.[Medline] [Order article via Infotrieve]
23. Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol. 1998;81:18B25B.[Medline] [Order article via Infotrieve]
24. Chaitman B. Exercise stress testing. In: Braunwald E, ed. Heart Disease, a Textbook of Cardiovascular Medicine. 4th ed. Philadelphia, Pa: WB Saunders; 1992:161179.
25. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem. 1972;18:499502.[Abstract]
26.
Marcovina SM, Albers JJ, Kennedy H, Mei JV, Henderson
LO, Hannon WH. International federation of clinical chemistry
standardization project for measurements of apolipoproteins A1 and
B. Clin Chem. 1994;40:586592.
27. Brandsom A, Johnson O, Dahlén GH, Rånby M. Lp(a) levels in healthy population measured by a new enzyme linked immunosorbent assay. Thromb Haemost. 1989;62:573.
28. Müllner S, Neubauer H, König W. A radioimmunoassay for the determination of insulins from several animal species, insulin derivatives and insulin precursors in both their native and denatured state. J Immunol Methods. 1991;140:211218.[Medline] [Order article via Infotrieve]
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and ß-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412419.[Medline] [Order article via Infotrieve]
30. DOrleans JP, Lidbury PS, Warner TD, Vane JR. Intravascular big endothelin increases circulating levels of endothelin-1 and prostanoids in the rabbit. Biochem Pharmacol. 1990;39:R21R22.[Medline] [Order article via Infotrieve]
31. Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens. 1997;15:317.[Medline] [Order article via Infotrieve]
32. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, Murphy TJ. Molecular cloning and characterization of the constitutive bovine endothelial cell nitric oxide synthase. J Clin Invest. 1992;90:20922096.
33. Huonker M, Halle M, Keul J. Structural and functional adaptations of the cardiovascular system by training. Int J Sports Med. 1996;17(suppl 3):S164S172.
34. Healy B. Endothelial cell dysfunction: an emerging endocrinopathy linked to coronary disease. J Am Coll Cardiol. 1990;16:357358.[Medline] [Order article via Infotrieve]
35. Hogan JC, Lewis MJ, Henderson AH. In vivo EDRF activity influences platelet function. Br J Pharmacol. 1988;94:10201022.[Medline] [Order article via Infotrieve]
36. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:17741777.
This article has been cited by other articles:
![]() |
L. Payvandi, A. Dyer, D. McPherson, P. Ades, J. Stein, K. Liu, L. Ferrucci, M. H Criqui, J. M Guralnik, D. Lloyd-Jones, et al. Physical activity during daily life and brachial artery flow-mediated dilation in peripheral arterial disease Vascular Medicine, August 1, 2009; 14(3): 193 - 201. [Abstract] [PDF] |
||||
![]() |
K. Aizawa, J. K. Shoemaker, T. J. Overend, and R. J. Petrella Metabolic syndrome, endothelial function and lifestyle modification Diabetes and Vascular Disease Research, July 1, 2009; 6(3): 181 - 189. [Abstract] [PDF] |
||||
![]() |
P. K. Garg, K. Liu, L. Tian, J. M. Guralnik, L. Ferrucci, M. H. Criqui, J. Tan, and M. M. McDermott Physical Activity During Daily Life and Functional Decline in Peripheral Arterial Disease Circulation, January 20, 2009; 119(2): 251 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Seals, C. A. DeSouza, A. J. Donato, and H. Tanaka Habitual exercise and arterial aging J Appl Physiol, October 1, 2008; 105(4): 1323 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Padilla, R. A Harris, L. D Rink, and J. P Wallace Characterization of the brachial artery shear stress following walking exercise Vascular Medicine, May 1, 2008; 13(2): 105 - 111. [Abstract] [PDF] |
||||
![]() |
M. A. Black, N. T. Cable, D. H.J. Thijssen, and D. J. Green Importance of Measuring the Time Course of Flow-Mediated Dilatation in Humans Hypertension, February 1, 2008; 51(2): 203 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kodama, S. Tanaka, K. Saito, M. Shu, Y. Sone, F. Onitake, E. Suzuki, H. Shimano, S. Yamamoto, K. Kondo, et al. Effect of Aerobic Exercise Training on Serum Levels of High-Density Lipoprotein Cholesterol: A Meta-analysis Arch Intern Med, May 28, 2007; 167(10): 999 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M Hill, J. D Buckley, K. J Murphy, and P. R. Howe Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1267 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lteif, P. Vaishnava, A. D. Baron, and K. J. Mather Endothelin Limits Insulin Action in Obese/Insulin-Resistant Humans Diabetes, March 1, 2007; 56(3): 728 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yoshida, H. Ikeda, K. Sugi, and T. Imaizumi Impaired Endothelium-Dependent and -Independent Vasodilation in Young Female Athletes With Exercise-Associated Amenorrhea Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): 231 - 232. [Full Text] [PDF] |
||||
![]() |
A.A. Lteif, K. Han, and K.J. Mather Obesity, Insulin Resistance, and the Metabolic Syndrome: Determinants of Endothelial Dysfunction in Whites and Blacks Circulation, July 5, 2005; 112(1): 32 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Bots, J. Westerink, T. J. Rabelink, and E. J.P. de Koning Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response Eur. Heart J., February 2, 2005; 26(4): 363 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Roberts and R. J. Barnard Effects of exercise and diet on chronic disease J Appl Physiol, January 1, 2005; 98(1): 3 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Benjamin, M. G. Larson, M. J. Keyes, G. F. Mitchell, R. S. Vasan, J. F. Keaney Jr, B. T. Lehman, S. Fan, E. Osypiuk, and J. A. Vita Clinical Correlates and Heritability of Flow-Mediated Dilation in the Community: The Framingham Heart Study Circulation, February 10, 2004; 109(5): 613 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Hamdy, S. Ledbury, C. Mullooly, C. Jarema, S. Porter, K. Ovalle, A. Moussa, A. Caselli, A. E. Caballero, P. A. Economides, et al. Lifestyle Modification Improves Endothelial Function in Obese Subjects With the Insulin Resistance Syndrome Diabetes Care, July 1, 2003; 26(7): 2119 - 2125. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Stewart, W. R. Hiatt, J. G. Regensteiner, and A. T. Hirsch Exercise Training for Claudication N. Engl. J. Med., December 12, 2002; 347(24): 1941 - 1951. [Full Text] [PDF] |
||||
![]() |
K. J. Stewart Exercise Training and the Cardiovascular Consequences of Type 2 Diabetes and Hypertension: Plausible Mechanisms for Improving Cardiovascular Health JAMA, October 2, 2002; 288(13): 1622 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fuchsjager-Mayrl, J. Pleiner, G. F. Wiesinger, A. E. Sieder, M. Quittan, M. J. Nuhr, C. Francesconi, H.-P. Seit, M. Francesconi, L. Schmetterer, et al. Exercise Training Improves Vascular Endothelial Function in Patients with Type 1 Diabetes Diabetes Care, October 1, 2002; 25(10): 1795 - 1801. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Imamura, S. Biro, T. Kihara, S. Yoshifuku, K. Takasaki, Y. Otsuji, S. Minagoe, Y. Toyama, and C. Tei Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1083 - 1088. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |